Performance analysis of Insight Molecular Diagnostics (IMDX)
Annual Return
Over the past 3 years, IMDX has had an average annual return of +4.60%, underperforming the benchmark SPY, which returned +19.63% annual.
Over the past 5 years, IMDX has had an average annual return of -46.06%, underperforming the benchmark SPY, which returned +12.73% annual.
Over the past 10 years, IMDX has had an average annual return of -23.83%, underperforming the benchmark SPY, which returned +15.04% annual.
Since Jan 4, 2016, IMDX has had an average annual return of -28.79%, underperforming the benchmark SPY, which returned +15.12% annual.
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -33.33% | +215.91% | -5.04% | -61.06% | -85.19% | -9.22% | +6.24% | +63.08% | -70.33% | -34.04% | -21.67% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -13.19% | -7.73% | -45.51% | +22.53% | +54.71% | -4.93% | -15.24% | -33.33% | |||||
| 2025 | -12.88% | +35.65% | +8.97% | +0.59% | +7.60% | -8.70% | -16.67% | +0.71% | +30.50% | +81.52% | +2.10% | +22.29% | +215.91% |
| 2024 | +23.74% | -5.81% | +0.62% | -15.34% | +10.14% | +7.89% | +6.10% | -0% | -9.20% | +6.33% | -19.05% | -2.94% | -5.04% |
| 2023 | +19.89% | -5.61% | -2.48% | -22.84% | -22.04% | +8.02% | -9.38% | -14.22% | -13.07% | -26.59% | +66.14% | -34.12% | -61.06% |
| 2022 | -21.65% | -14.13% | +2.10% | -22.16% | -6.90% | -16.67% | -7.00% | -5.59% | -7.63% | -6.29% | -31.32% | -31.61% | -85.19% |
| 2021 | +114.19% | -3.90% | +5.49% | -0.97% | -14.01% | +29.87% | -10.46% | -20.22% | -13.17% | -7.89% | -31.39% | -3.56% | -9.22% |
| 2020 | +16% | -17.62% | +13.94% | +10.21% | +2.23% | -30.81% | -29.31% | -7.40% | +11.16% | +6.48% | +30.41% | +23.88% | +6.24% |
| 2019 | +241.36% | -29.51% | +18.98% | +8.86% | -8.60% | -36.64% | -28.91% | +11.85% | +6.05% | -19.03% | +3.55% | +27.81% | +63.08% |
| 2018 | -11.83% | -19.51% | -36.38% | +2.40% | +51.15% | -21.55% | -3.92% | +4.08% | -1.94% | -28.01% | -5.55% | -18.85% | -70.33% |
| 2017 | -21.27% | +1.80% | +5.30% | +0% | -6.72% | -6.31% | -24.04% | +43.04% | +33.63% | -19.87% | -16.53% | -7.91% | -34.04% |
Drawdown analysis of Insight Molecular Diagnostics (IMDX)
The maximum drawdown for the IMDX was -99.03%, occurring on Jan 22, 2025. This drawdown has not yet recovered.
The current IMDX drawdown is -97.53%.
Since Jan 4, 2016 IMDX has experienced the following drawdowns:
- 50% or more: 1 time
- 40% or more: 1 time
- 30% or more: 1 time
- 20% or more: 1 time
- 10% or more: 1 time
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -99.03% | Jan 5, 2016 | 2275 | Jan 22, 2025 | Ongoing | Ongoing | Ongoing |